The present invention relates to a novel quinoline derivative compound, an optical isomer thereof, a pharmaceutically acceptable salt thereof, and a hydrate or a solvate thereof. The novel quinoline derivative compound, the optical isomer thereof, the pharmaceutically acceptable salt thereof, and the hydrate or the solvate thereof accelerates gastrointestinal movement, and thus can effectively prevent or treat gastrointestinal motility disorders.
本发明涉及一种新型
喹啉衍
生物化合物,其光学异构体,其药学上可接受的盐以及其
水合物或溶剂化物。该新型
喹啉衍
生物化合物,其光学异构体,其药学上可接受的盐以及其
水合物或溶剂化物可以加速胃肠道运动,从而有效预防或治疗胃肠道运动障碍。